Results 91 to 100 of about 529 (145)

Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial. [PDF]

Nat Cancer
Kendra KL, Bellasea SL, Eroglu Z, Hu-Lieskovan S, Campbell KM, Carson WE, Wada DA, Plaza JA, In GK, Ikeguchi A, Hyngstrom J, Brohl AS, Chmielowski B, Khushalani NI, Markowitz J, Monroe M, Contreras CM, Bowles T, Norman K, Medina E, Gonzalez CR, Baselga-Carretero I, Garcilazo IP, Vega-Crespo A, Chen JM, Deen NNA, Patel SP, Grossmann KF, Sondak VK, Sharon E, Moon J, Wu MC, Ribas A.   +32 more
europepmc   +1 more source

Network-Integrated Platform for Clinical Trial Navigation from the New South Wales Early Phase Clinical Trials Alliance. [PDF]

Clin Cancer Res
Liu J, Farrow M, Hsing SS, Cosman R, Lemech CR, Teng C, Pal A, Nindra U, Parsonson AO, Park JJW, Rodrigues A, Chan WY, Wei J, Cohen J, Underhill CR, Brungs D, Hui M, Nagrial A, Jain S, Joshua AM.   +19 more
europepmc   +1 more source

Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion stage of a multicentre, open-label, phase I trial. [PDF]

Br J Cancer, 2023
Friedlander M, Mileshkin L, Lombard J, Frentzas S, Gao B, Wilson M, Meniawy T, Baron-Hay S, Briscoe K, McCarthy N, Fountzilas C, Cervantes A, Ge R, Wu J, Spira A.   +14 more
europepmc   +1 more source

Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and Advanced Solid Tumors. [PDF]

J Clin Oncol
Sharma MR, Powderly J, Kuboki Y, Strickler JH, Perets R, Cohen JE, Raimbourg J, Nakajima TE, Yamamoto N, Cruz-Correa M, O'Neil B, Ghiringhelli F, Raghav K, Cecchini M, Bar J, Hunter Z, Burns M, Blaney M, Morrison-Thiele G, Aristide MN, Freise KJ, Li R, Li M, Vasilopoulos A, Biesdorf C, Sommerhalder D.   +25 more
europepmc   +1 more source

IPH5201, an Anti-CD39 mAb, as Monotherapy or in Combination with Durvalumab in Advanced Solid Tumors. [PDF]

Cancer Res Commun
Powderly J, Imbimbo M, Italiano A, Martin-Romano P, McKean M, Macarulla T, Castañón Alvarez E, Carneiro BA, Mager R, Barnhart V, Eck S, Murtomaki E, Loembé AB, He Y, Cooper ZA, Tu E, Fan C, Boyer Chamard A, Paturel C, Fraenkel PG, Hollebecque A.   +20 more
europepmc   +1 more source

First-in-human phase I open-label study of the LAG-3 antagonist antibody INCAGN02385 in patients with select advanced or metastatic solid tumors. [PDF]

Oncologist
Powderly JD, Gutierrez ME, Balmanoukian AS, Hoyle PE, Dong Z, Cheng L, Chen X, Janik JE, Bourayou N, Hamid O.   +9 more
europepmc   +1 more source

First-in-Human, Phase I/II Dose Escalation and Expansion Study of Zelenectide Pevedotin in Patients With Advanced Solid Tumors: Results From Monotherapy Dose Escalation. [PDF]

J Clin Oncol
Baldini C, Verlingue L, Goldschmidt V, Doger de Spéville B, Lostes J, Italiano A, Cousin S, Falchook GS, Necchi A, Reig Torras O, Fontana E, Carter L, Rodon Ahnert J, Brown JR, DeMars LR, Josephs K, Dickson A, Xu C, Bader J, Campbell C, Sharma R, McKean M.   +21 more
europepmc   +1 more source

Proceedings of the seventh annual Women in Melanoma Conference. [PDF]

Ther Adv Med Oncol
Najjar YG, Orloff M, Mitchell TC, Bowles TL, Betof Warner A, Bollin K, Chandra S, Cohen JV, Eroglu Z, Funchain P, Gaughan E, Glitza Oliva I, Hsu S, Hu-Lieskovan S, Kennedy LB, Truong TG, McKean M, Mehnert J, Moon H, Tsai KK, Wilson M, Tran T, Buchbinder EI, Fecher LA, Guild S, Patel SP.   +25 more
europepmc   +1 more source

Datopotamab Deruxtecan in Advanced or Metastatic Non-Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study. [PDF]

J Clin Oncol
Sands J, Ahn MJ, Lisberg A, Cho BC, Blumenschein G, Shum E, Pons Tostivint E, Goto Y, Yoh K, Heist R, Shimizu J, Lee JS, Baas P, Planchard D, Pérol M, Felip E, Su WC, Zebger-Gong H, Lan L, Liu C, Howarth P, Chiaverelli R, Paz-Ares L.   +22 more
europepmc   +1 more source

Phase Ib Trial of Bavdegalutamide (ARV-110) in Combination with Abiraterone for Metastatic Prostate Cancer. [PDF]

Clin Cancer Res
Smoragiewicz M, Bernard-Tessier A, Linch M, Shen J, Shore ND, Parikh O, Chi KN, Sokolova AO, Culine S, McKean M, Gleave M, Devitt ME, Zhi E, Gong J, Landrette S, Colasanto M, Patel V, Gao X.   +17 more
europepmc   +1 more source